1Speyer JL, et al.The rationale behind intraperitoneal chermotherapy in gastrointestinal malignancies. Semin Oncol, 1985,12: 23
2Douglass HO, Jrgastric cancer: Overview of current of therapies. Semin Oncol, 1985, 12: 57～62
3Sugarbaker PH, Cunliff WJ, Belliveall JF, et al. Rationale for integrating early postoperatiove intraperitoneal chemotherapy into the surgical treatment of gastrointestinal cancer. Semin Oncol, 1989, 16: 83～97
4Pickering JW, et al. Liver matastasis:Analysis of autopsy data, in Weiss L, Gilbert HA(eds) :Liver Metastasis. Boston, GK Hall, 1982, 12～ 18
5Sugarbaker PH.Rationale for perioperative intraperitoneal chemotherapy as a surgical adjuvant for gastrointestinal malignancy. Reg Cancer Treat,1988,1:66
6McClay RL.Areview: Intraperitoneal Clisplatin in the management of patients with overian cancer. Gynecol Oncol, 1990,36(1): 1～6
7Dedrick RL. Phamacokinefic ralionale for paritoneal drug administration in the treatment of ovenan cancer. Cancer Treat Rep, 1978, 62: 1 ～ 11
8Sugarbaker PH. Intraperitoneal chemztherapy for treatment and prevention of peritoneal carcinomatosis and sarcomatosis. Dis Colon Recttn,1994, 37: 115
9Howe11 SB. Intraperitoneal chemotherapy:The use of concurrent systemic neutralizing agents. Senin Oncol, 1985,12: 17
10PiccartMT, et al. Intraperitoneal chemotherapy:Technical experience at five institttions. Semin Oncol, 1985,12: 90～96
